COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 1117: Articles 11161-11170  | Next

Systems immune profiling of variant-specific vaccination against SARS-CoV-2
Peng, L., Park, J., Fang, Z., Zhou, X., Dong, M., Xiong, Q., Lin, C., Chen, S.
10.1101/2021.12.02.471028 — Posted: 2021-12-03
Secreted ORF8 is a pathogenic cause of severe Covid-19 and potentially targetable with select NLRP3 inhibitors
Wu, X., Manske, M. K., Ruan, G., Nowakowski, K. E., Abeykoon, J. P., Tang, X., Yu, Y., Witter, T. L., Taupin, V., Paludo, J., Ansell, S. M., Badley, A. D., Schellenberg, M., Witzig, T. E.
10.1101/2021.12.02.470978 — Posted: 2021-12-03
Drug repurposing screening identified tropifexor as a SARS-CoV-2 papain-like protease inhibitor
Ma, C., Wang, Y., Choza, J., Wang, J.
10.1101/2021.12.02.471030 — Posted: 2021-12-03
SARS-CoV-2 wildlife surveillance in Ontario and Quebec, Canada
Greenhorn, J. E., Kotwa, J. D., Bowman, J., Bruce, L., Buchanan, T., Buck, P. A., Dibernardo, A., Flockhart, L., Gagnier, M., Hou, A., Jardine, C. M., Lair, S., Lindsay, L. R., Masse, A., Muchaal, P. K., Nituch, L. A., Sotto, A., Stevens, B., Yip, L., Mubareka, S.
10.1101/2021.12.02.470924 — Posted: 2021-12-03
Investigating the human host - ssRNA virus interaction landscape using the SMEAGOL toolbox
Lal, A., Ferrarini, M. G., Gruber, A. J.
10.1101/2021.12.02.470930 — Posted: 2021-12-03
Macaque-human differences in SARS-CoV-2 Spike antibody response elicited by vaccination or infection
Willcox, A., Sung, K., Garrett, M. E., Galloway, J. G., OConnor, M. A., Erasmus, J. H., Logue, J. K., Hawman, D. W., Chu, H. Y., Hasenkrug, K. J., Fuller, D. H., Matsen, F. A., Overbaugh, J.
10.1101/2021.12.01.470697 — Posted: 2021-12-03
A public antibody class recognizes a novel S2 epitope exposed on open conformations of SARS-CoV-2 spike
Claireaux, M., Caniels, T. G., de Gast, M., Han, J., Guerra, D., Kerster, G., van Schaik, B. D., Jongejan, A., Schriek, A. I., Grobben, M., Brouwer, P. J., van der Straten, K., Aldon, Y., Capella-Pujol, J., Snitselaar, J. L., Olijhoek, W., Aartse, A., Brinkkemper, M., Bontjer, I., Burger, J. A., Poniman, M., Bijl, T. P., Torres, J. L., Copps, J., Martin, I. C., de Taeye, S. W., de Bree, G. J., Ward, A. B., Sliepen, K., van Kampen, A. H., Moerland, P. D., Sanders, R. W., van Gils, M. J.
10.1101/2021.12.01.470767 — Posted: 2021-12-03
ScRNA-Seq study of neutrophils reveals vast heterogeneity and breadth of inflammatory responses in severe COVID-19 patients
Xu, J., He, B., Carver, K., Vanheyningen, D., Parkin, B., Garmire, L., Olszewski, M. A., Deng, J. A.
10.1101/2021.12.01.470817 — Posted: 2021-12-03
Investigating the mutational landscape of the SARS-CoV-2 Omicron variant via ab initio quantum mechanical modeling
Genovese, L., Zaccaria, M., Farzan, M., Johnson, W. E., Momeni, B.
10.1101/2021.12.01.470748 — Posted: 2021-12-03
Thermal Analysis of Protein Stability and Ligand Binding in Complex Media
Eskew, M. W., Benight, A. S.
10.1101/2021.12.01.470796 — Posted: 2021-12-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).